Mean telomere length and risk of incident venous thromboembolism: A prospective, nested case-control approach

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 148-150

  Zee, Robert Y L ^a   Michaud, Sherri E ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Mean telomere length; Risk factor; VTE

Indexed keywords

GENOMIC DNA;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TELOMERE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RISK; VENOUS THROMBOEMBOLISM;

EID: 67650217492     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.014     Document Type: Article

References (14)

1. Fuster J.J., and Andres V. Telomere biology and cardiovascular disease. Circ Res 99 (2006) 1167-1180
2. van der Harst P., van der Steege G., de Boer R.A., et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49 (2007) 1459-1464
3. Kurz D.J., Kloeckener-Gruissem B., Akhmedov A., et al. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler Thromb Vasc Biol 26 (2006) e114-e117
4. Ogami M., Ikura Y., Ohsawa M., et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 24 (2004) 546-550
5. Brouilette S.W., Moore J.S., McMahon A.D., et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369 (2007) 107-114
6. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., and Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23 (2003) 842-846
7. Physician's health study: aspirin and primary prevention of coronary heart disease. N Engl J Med 321 (1989) 1825-1828
8. Ridker P.M., Miletich J.P., Hennekens C.H., and Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. Jama 277 (1997) 1305-1307
9. Zee R.Y., Michaud S.M., Germer S., and Ridker P.M. Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach. Clin Chim Acta 403 (2009) 139-141
10. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 30 (2002) e47
11. Harley C.B. Telomerase therapeutics for degenerative diseases. Curr Mol Med 5 (2005) 205-211
12. Zhang P., Dilley C., and Mattson M.P. DNA damage responses in neural cells: focus on the telomere. Neuroscience 145 (2007) 1439-1448
13. Martin-Ruiz C., Dickinson H.O., Keys B., Rowan E., Kenny R.A., and Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 60 (2006) 174-180
14. von Zglinicki T., Serra V., Lorenz M., et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?. Lab Invest 80 (2000) 1739-1747